About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Livestock Vaccines Market

Livestock Vaccines Market Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Livestock Vaccines Market by Type (Inactivated, Live Attenuated, Recombinant, Others), by Animal Type (Bovine, Swine/ Porcine, Poultry, Others), by Route of Adminstration (Oral, Parenteral, Others), by Distributional Channel (Veterinary Hospitals, Veterinary Clinics, Others), by By Geography (North America) Forecast 2026-2034

Jun 21 2025

Base Year: 2025

180 Pages

Livestock Vaccines Market Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Key Insights

The global livestock vaccines market is projected to grow from USD 8.3 billion in 2023 to USD 11 billion by 2028, at a CAGR of 5.8%. The growth is attributed to the increasing demand for safe and effective livestock vaccines to prevent and control diseases in animals. Vaccines for livestock are the major instruments in the health management of animals, which are the key players in disease prevention and control. There are different types of vaccines, for instance, attenuated, inactivated, subunit, and DNA vaccines, all of which are built to provoke the respective immune reactions. The attenuated vaccines have pathogens that are a little weaker than the natural ones, but still, they can be similar to what happens in the natural infection without causing the actual disease. Inert vaccines are made of dead pathogens, which consequently stimulate the immune system without the danger of infection. Subunit vaccines are the ones that have only the necessary antigens, thus they are quite safe and effective. DNA vaccines function by the use of the genetic material that induces immune responses. These vaccines are the main cause of prevention of diseases like foot-and-mouth disease, brucellosis, and avian influenza thus enabling animal welfare, economic stability, and public health safety.

Livestock Vaccines Trends

Growing prevalence of animal diseases
Rising demand for quality and safe meat products
Government regulations mandating vaccination programs
Technological advancements in vaccine development
Increasing emphasis on animal welfare

Livestock Vaccines Market Market Size and Forecast (2024-2030) — Livestock Vaccines Market Company Market Share

Driving Forces: What's Propelling the Livestock Vaccines Market

Increasing Prevalence of Livestock Diseases: The escalating incidence of highly contagious and economically devastating diseases like Foot and Mouth Disease (FMD), African Swine Fever (ASF), Avian Influenza (AI), and Bovine Tuberculosis (TB) underscores the critical role of vaccination in safeguarding animal health and global food security. These outbreaks cause significant economic losses through livestock mortality, reduced productivity, trade restrictions, and disruptions to supply chains.
Rising Global Demand for Animal-Source Foods: A burgeoning global population, coupled with shifting dietary preferences towards increased meat and dairy consumption, fuels the demand for efficient and sustainable livestock production. Vaccination plays a crucial role in ensuring healthy livestock populations capable of meeting this growing demand while minimizing disease-related losses.
Advancements in Vaccine Technology and Delivery Systems: Significant breakthroughs in vaccine technology, including the development of novel vaccine platforms (e.g., subunit, DNA, RNA vaccines), improved adjuvants, and innovative delivery systems (e.g., intranasal, needle-free), are leading to safer, more efficacious, and cost-effective vaccines. These advancements are enhancing vaccine efficacy, broadening their applicability, and simplifying administration.
Stringent Government Regulations and Biosecurity Measures: Governments worldwide are implementing increasingly stringent regulations and biosecurity protocols to prevent and control the spread of animal diseases. These measures often mandate vaccination programs for specific livestock species in certain regions, driving market growth and ensuring public health safety.
Growing Focus on Antimicrobial Resistance (AMR): The rise of antimicrobial resistance necessitates a shift towards preventative measures, such as vaccination, to minimize the use of antibiotics in livestock. This trend is further propelling the demand for livestock vaccines.

Challenges and Restraints in the Livestock Vaccines Market

High Cost and Limited Access: Vaccines can be expensive, and their efficacy can vary depending on animal type and disease prevalence.
Vaccine Resistance: The emergence of vaccine-resistant pathogens poses a significant challenge to the effectiveness of immunization programs.
Stringent Regulatory Environment: The development and approval of livestock vaccines require rigorous testing and adherence to regulatory standards, which can be time-consuming and costly.
Limited Awareness and Adoption: In some regions, there is still a lack of awareness about the benefits of livestock vaccination, leading to low adoption rates.

Emerging Trends in Livestock Vaccines

Development of Multivalent Vaccines: Vaccines that protect against multiple diseases in a single shot.
Genetic Engineering: Advances in genetic engineering are improving the safety and efficacy of vaccines.
Nanotechnology: The use of nanotechnology is being explored to enhance vaccine delivery and immune response.

Growth Catalysts in Livestock Vaccines Industry

Investment in Research and Development: Pharmaceutical companies are investing significantly in R&D to develop innovative and more effective vaccines. This investment is driven by the need to address emerging and evolving diseases and improve vaccine efficacy.
Government Support: Governments worldwide provide incentives and support for livestock vaccination programs to reduce the incidence of animal diseases and promote public health. This support includes financial assistance, technical training, and access to veterinary services.
Consumer Education: Increasing consumer awareness about livestock health and the benefits of vaccination is driving market growth. Educational campaigns and media coverage have highlighted the importance of vaccinations in protecting livestock and ensuring a safe food supply.

Market Segmentation: Livestock Vaccines Analysis

Type

Inactivated
Live Attenuated
Recombinant
Others

Animal Type

Bovine
Swine/ Porcine
Poultry
Others

Route of Administration

Oral
Parenteral
Others

Distributional Channel

Veterinary Hospitals
Veterinary Clinics
Others

Leading Players in the Livestock Vaccines Market

Boehringer Ingelheim International GmbH (Germany)
Virbac (France)
Merck Animal Health (Merck & Co., Inc.) (U.S.)
Zoetis Services LLC (U.S.)
Ceva (France)
Elanco (U.S.)
HIPRA (Spain)
Neogen Corporation (U.S.)

Significant Developments in the Livestock Vaccines Sector

2023: Virbac announces the first vaccine for sows to protect piglets from rotavirus diarrhea.
2022: Merck Animal Health acquires Vence to advance animal health technologies.
2022: Virbac partners with Pharmgate for U.S. market expansion in the swine segment.
2021: Boehringer Ingelheim invests USD 105.2 million to expand vaccine capacity in France.
2021: U.K. establishes the U.K. Animal Vaccine Manufacturing and Innovation Centre.
2021: Ceva partners with INRAE for R&D in animal health and disease prevention.

Comprehensive Coverage Livestock Vaccines Market Report

Market size and forecast
Market segmentation and growth analysis
Competitive landscape and key players
Industry trends and drivers
Research and development activities
Regulatory environment
Future outlook

Regional Insight

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Livestock Vaccines Market Market Share by Region - Global Geographic Distribution — Livestock Vaccines Market Regional Market Share

DROCs

Drivers: Increasing disease prevalence, rising demand for animal products
Restraints: High cost, vaccine resistance
Opportunities: Technological advancements, investment in R&D
Challenges: Stringent regulatory environment, limited awareness

Pricing Analysis

Vaccine costs vary based on type, animal species, and route of administration.
Government subsidies and incentives can impact vaccine pricing.

Import And Export Analysis

Major exporters: U.S., U.K., France
Major importers: China, India, Brazil

Patent/Trademark Analysis

Companies are actively filing patents to protect their vaccine technologies and trademarks.
Competition is high in the livestock vaccine market, and intellectual property rights play a significant role.

Geographic Coverage of Livestock Vaccines Market

Higher Coverage

Lower Coverage

No Coverage

Livestock Vaccines Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 5.8% from 2020-2034
Segmentation	By Type Inactivated Live Attenuated Recombinant Others By Animal Type Bovine Swine/ Porcine Poultry Others By Route of Adminstration Oral Parenteral Others By Distributional Channel Veterinary Hospitals Veterinary Clinics Others By Geography By Geography North America

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Rising Prevalence of Disease is Presenting a Large Patient Pool Undergoing Treatment
- - 3.3. Market Restrains
  - - 3.3.1. Adverse Effects Assocaited with Vaccines Might Hamper the Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Global Livestock Vaccines Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
  - 5.1.1. Inactivated
  - 5.1.2. Live Attenuated
  - 5.1.3. Recombinant
  - 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by Animal Type
  - 5.2.1. Bovine
  - 5.2.2. Swine/ Porcine
  - 5.2.3. Poultry
  - 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by Route of Adminstration
  - 5.3.1. Oral
  - 5.3.2. Parenteral
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Distributional Channel
  - 5.4.1. Veterinary Hospitals
  - 5.4.2. Veterinary Clinics
  - 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - by Region
  - 5.5.1. By Geography
6. Competitive Analysis
- 6.1. Global Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Boehringer Ingelheim International GmbH (Germany)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Virbac (France)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Merck Animal Health (Merck & Co. Inc.) (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Zoetis Services LLC (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Ceva (France)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Elanco (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 HIPRA (Spain)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Neogen Corporation (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)

List of Figures

Figure 1: Global Livestock Vaccines Market Revenue Breakdown (USD billion, %) by Region 2025 & 2033
Figure 2: Global Livestock Vaccines Market Volume Breakdown (No.of doses, %) by Region 2025 & 2033
Figure 3: By Geography Livestock Vaccines Market Revenue (USD billion), by Type 2025 & 2033
Figure 4: By Geography Livestock Vaccines Market Volume (No.of doses), by Type 2025 & 2033
Figure 5: By Geography Livestock Vaccines Market Revenue Share (%), by Type 2025 & 2033
Figure 6: By Geography Livestock Vaccines Market Volume Share (%), by Type 2025 & 2033
Figure 7: By Geography Livestock Vaccines Market Revenue (USD billion), by Animal Type 2025 & 2033
Figure 8: By Geography Livestock Vaccines Market Volume (No.of doses), by Animal Type 2025 & 2033
Figure 9: By Geography Livestock Vaccines Market Revenue Share (%), by Animal Type 2025 & 2033
Figure 10: By Geography Livestock Vaccines Market Volume Share (%), by Animal Type 2025 & 2033
Figure 11: By Geography Livestock Vaccines Market Revenue (USD billion), by Route of Adminstration 2025 & 2033
Figure 12: By Geography Livestock Vaccines Market Volume (No.of doses), by Route of Adminstration 2025 & 2033
Figure 13: By Geography Livestock Vaccines Market Revenue Share (%), by Route of Adminstration 2025 & 2033
Figure 14: By Geography Livestock Vaccines Market Volume Share (%), by Route of Adminstration 2025 & 2033
Figure 15: By Geography Livestock Vaccines Market Revenue (USD billion), by Distributional Channel 2025 & 2033
Figure 16: By Geography Livestock Vaccines Market Volume (No.of doses), by Distributional Channel 2025 & 2033
Figure 17: By Geography Livestock Vaccines Market Revenue Share (%), by Distributional Channel 2025 & 2033
Figure 18: By Geography Livestock Vaccines Market Volume Share (%), by Distributional Channel 2025 & 2033
Figure 19: By Geography Livestock Vaccines Market Revenue (USD billion), by Country 2025 & 2033
Figure 20: By Geography Livestock Vaccines Market Volume (No.of doses), by Country 2025 & 2033
Figure 21: By Geography Livestock Vaccines Market Revenue Share (%), by Country 2025 & 2033
Figure 22: By Geography Livestock Vaccines Market Volume Share (%), by Country 2025 & 2033

List of Tables

Table 1: Global Livestock Vaccines Market Revenue USD billion Forecast, by Type 2020 & 2033
Table 2: Global Livestock Vaccines Market Volume No.of doses Forecast, by Type 2020 & 2033
Table 3: Global Livestock Vaccines Market Revenue USD billion Forecast, by Animal Type 2020 & 2033
Table 4: Global Livestock Vaccines Market Volume No.of doses Forecast, by Animal Type 2020 & 2033
Table 5: Global Livestock Vaccines Market Revenue USD billion Forecast, by Route of Adminstration 2020 & 2033
Table 6: Global Livestock Vaccines Market Volume No.of doses Forecast, by Route of Adminstration 2020 & 2033
Table 7: Global Livestock Vaccines Market Revenue USD billion Forecast, by Distributional Channel 2020 & 2033
Table 8: Global Livestock Vaccines Market Volume No.of doses Forecast, by Distributional Channel 2020 & 2033
Table 9: Global Livestock Vaccines Market Revenue USD billion Forecast, by Region 2020 & 2033
Table 10: Global Livestock Vaccines Market Volume No.of doses Forecast, by Region 2020 & 2033
Table 11: Global Livestock Vaccines Market Revenue USD billion Forecast, by Type 2020 & 2033
Table 12: Global Livestock Vaccines Market Volume No.of doses Forecast, by Type 2020 & 2033
Table 13: Global Livestock Vaccines Market Revenue USD billion Forecast, by Animal Type 2020 & 2033
Table 14: Global Livestock Vaccines Market Volume No.of doses Forecast, by Animal Type 2020 & 2033
Table 15: Global Livestock Vaccines Market Revenue USD billion Forecast, by Route of Adminstration 2020 & 2033
Table 16: Global Livestock Vaccines Market Volume No.of doses Forecast, by Route of Adminstration 2020 & 2033
Table 17: Global Livestock Vaccines Market Revenue USD billion Forecast, by Distributional Channel 2020 & 2033
Table 18: Global Livestock Vaccines Market Volume No.of doses Forecast, by Distributional Channel 2020 & 2033
Table 19: Global Livestock Vaccines Market Revenue USD billion Forecast, by Country 2020 & 2033
Table 20: Global Livestock Vaccines Market Volume No.of doses Forecast, by Country 2020 & 2033
Table 21: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 22: North America Livestock Vaccines Market Volume (No.of doses) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Livestock Vaccines Market?

The projected CAGR is approximately 5.8%.

2. Which companies are prominent players in the Livestock Vaccines Market?

Key companies in the market include Boehringer Ingelheim International GmbH (Germany), Virbac (France), Merck Animal Health (Merck & Co., Inc.) (U.S.), Zoetis Services LLC (U.S.), Ceva (France), Elanco (U.S.), HIPRA (Spain), Neogen Corporation (U.S.).

3. What are the main segments of the Livestock Vaccines Market?

The market segments include Type, Animal Type, Route of Adminstration, Distributional Channel.

4. Can you provide details about the market size?

The market size is estimated to be USD 5.47 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Rising Prevalence of Disease is Presenting a Large Patient Pool Undergoing Treatment.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Adverse Effects Assocaited with Vaccines Might Hamper the Market Growth.

8. Can you provide examples of recent developments in the market?

February 2023- Virbac announced the first vaccine for sows to protect the piglets from diarrhea caused by rotavirus and assist pig farmers and veterinarians in the livestock industry.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion and volume, measured in No.of doses.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Livestock Vaccines Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Livestock Vaccines Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Livestock Vaccines Market?

To stay informed about further developments, trends, and reports in the Livestock Vaccines Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Vaccines Market Soars to USD Billion , witnessing a CAGR of 6.6 during the forecast period 2025-2033

U.S. Livestock Vaccines Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

Veterinary/Animal Vaccines Market Charting Growth Trajectories: Analysis and Forecasts 2025-2033

Livestock Animal Vaccination 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Livestock Vaccine Analysis Report 2025: Market to Grow by a CAGR of 5 to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report